SOL Stock Overview
SOL S.p.A. engages in the applied research, production, and marketing of technical and medical gases; and in home care activities and related medical equipment in Italy and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 2/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
SOL S.p.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €32.85 |
52 Week High | €33.30 |
52 Week Low | €23.05 |
Beta | 0.51 |
1 Month Change | 14.66% |
3 Month Change | 17.32% |
1 Year Change | 39.79% |
3 Year Change | 96.12% |
5 Year Change | 197.02% |
Change since IPO | 822.00% |
Recent News & Updates
SOL (BIT:SOL) Might Have The Makings Of A Multi-Bagger
Feb 09SOL (BIT:SOL) Seems To Use Debt Quite Sensibly
Dec 28Does SOL (BIT:SOL) Deserve A Spot On Your Watchlist?
Dec 10SOL (BIT:SOL) Is Experiencing Growth In Returns On Capital
Nov 04Recent updates
SOL (BIT:SOL) Might Have The Makings Of A Multi-Bagger
Feb 09SOL (BIT:SOL) Seems To Use Debt Quite Sensibly
Dec 28Does SOL (BIT:SOL) Deserve A Spot On Your Watchlist?
Dec 10SOL (BIT:SOL) Is Experiencing Growth In Returns On Capital
Nov 04Here's Why SOL (BIT:SOL) Can Manage Its Debt Responsibly
Sep 11Investors Will Want SOL's (BIT:SOL) Growth In ROCE To Persist
Jul 22With EPS Growth And More, SOL (BIT:SOL) Makes An Interesting Case
Jun 29Is SOL (BIT:SOL) Using Too Much Debt?
Apr 08SOL (BIT:SOL) Is Looking To Continue Growing Its Returns On Capital
Mar 08We Like These Underlying Return On Capital Trends At SOL (BIT:SOL)
Dec 07Is SOL (BIT:SOL) Using Too Much Debt?
Nov 10Weak Statutory Earnings May Not Tell The Whole Story For SOL (BIT:SOL)
Sep 24A Look At The Intrinsic Value Of SOL S.p.A. (BIT:SOL)
Jan 26SOL (BIT:SOL) Is Doing The Right Things To Multiply Its Share Price
Jan 11I Ran A Stock Scan For Earnings Growth And SOL (BIT:SOL) Passed With Ease
Dec 28SOL (BIT:SOL) Could Easily Take On More Debt
Nov 25A Look At The Intrinsic Value Of SOL S.p.A. (BIT:SOL)
Sep 29SOL (BIT:SOL) Is Experiencing Growth In Returns On Capital
Sep 12The Return Trends At SOL (BIT:SOL) Look Promising
May 31Is SOL S.p.A. (BIT:SOL) A Smart Choice For Dividend Investors?
Apr 07Are Institutions Heavily Invested In SOL S.p.A.'s (BIT:SOL) Shares?
Mar 12Update: SOL (BIT:SOL) Stock Gained 94% In The Last Five Years
Feb 10Is SOL S.p.A.'s (BIT:SOL) Latest Stock Performance A Reflection Of Its Financial Health?
Jan 12What We Make Of SOL's (BIT:SOL) Returns On Capital
Dec 25Calculating The Intrinsic Value Of SOL S.p.A. (BIT:SOL)
Dec 11What You Need To Know About SOL S.p.A.'s (BIT:SOL) Investor Composition
Nov 24Shareholder Returns
SOL | IT Chemicals | IT Market | |
---|---|---|---|
7D | 8.4% | 5.2% | 1.2% |
1Y | 39.8% | 22.0% | 26.4% |
Return vs Industry: SOL exceeded the Italian Chemicals industry which returned 22% over the past year.
Return vs Market: SOL exceeded the Italian Market which returned 26.4% over the past year.
Price Volatility
SOL volatility | |
---|---|
SOL Average Weekly Movement | 2.9% |
Chemicals Industry Average Movement | 3.9% |
Market Average Movement | 4.2% |
10% most volatile stocks in IT Market | 7.9% |
10% least volatile stocks in IT Market | 2.6% |
Stable Share Price: SOL has not had significant price volatility in the past 3 months.
Volatility Over Time: SOL's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1927 | 5,957 | Aldo Romario | https://www.solgroup.com |
SOL S.p.A. engages in the applied research, production, and marketing of technical and medical gases; and in home care activities and related medical equipment in Italy and internationally. The company offers technical and medical gases, including oxygen, nitrogen, argon, hydrogen, carbon and sulphur dioxide, acetylene, nitrous oxide, gas mixtures, high purity gases, food gases, and gaseous and liquid helium; gas for electronics; and ammonia and combustible gases for industrial use. It also provides oxygen therapy, home mechanical ventilation, and aerosol therapy services, as well as the diagnosis and treatment of respiratory sleep disorders; services for artificial nutrition, insulin therapy with pumps, and immunotherapy, as well as services for the treatment of pain and Parkinson's disease; home healthcare and social care services; telemedicine and digital services; and healthcare aids.
SOL S.p.A. Fundamentals Summary
SOL fundamental statistics | |
---|---|
Market cap | €2.98b |
Earnings (TTM) | €148.63m |
Revenue (TTM) | €1.53b |
20.0x
P/E Ratio2.0x
P/S RatioIs SOL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SOL income statement (TTM) | |
---|---|
Revenue | €1.53b |
Cost of Revenue | €1.20b |
Gross Profit | €321.98m |
Other Expenses | €173.35m |
Earnings | €148.63m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 1.64 |
Gross Margin | 21.10% |
Net Profit Margin | 9.74% |
Debt/Equity Ratio | 51.7% |
How did SOL perform over the long term?
See historical performance and comparison